Viewing Study NCT04034251


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-05 @ 1:57 AM
Study NCT ID: NCT04034251
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2019-07-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-06-09
Start Date Type: ACTUAL
Primary Completion Date: 2023-02-25
Primary Completion Date Type: ACTUAL
Completion Date: 2024-09-05
Completion Date Type: ACTUAL
First Submit Date: 2019-07-25
First Submit QC Date: None
Study First Post Date: 2019-07-26
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-10-26
Results First Submit QC Date: None
Results First Post Date: 2023-12-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-14
Last Update Post Date: 2025-02-03
Last Update Post Date Type: ACTUAL